Leborgne 1997.
Methods | RCT 1990‐1993 | |
Participants | 97 (0*) FIGO stage IB‐IVA (IB >4cm) | |
Interventions | CT + RT vs RT CT: CDDP 50mg/m2 VCR 3mg/m2 BLM 75mg/m2. Every 10 days for 3 cycles. RT: External beam 20‐60Gy in 10‐30F. Intracavitary 30Gy |
|
Outcomes | Survival Disease‐free survival Loco‐regional disease‐free survival Metastases‐free survival Late toxicity | |
Notes | Treatment comparison 1 | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Low risk | A ‐ Adequate |